Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.27B |
| 2 |
Apple
AAPL
|
+$2.66B |
| 3 |
Philip Morris
PM
|
+$1.71B |
| 4 |
Oracle
ORCL
|
+$1.63B |
| 5 |
NVIDIA
NVDA
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.92B |
| 2 |
UnitedHealth
UNH
|
+$2.3B |
| 3 |
Boeing
BA
|
+$2.28B |
| 4 |
Shopify
SHOP
|
+$1.22B |
| 5 |
Las Vegas Sands
LVS
|
+$1.09B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.32% |
| 2 | Healthcare | 13.6% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Financials | 10.03% |
| 5 | Industrials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Louisiana-Pacific
LPX
$5.18B
| $103M | 0.02% |
1,273,497
+960,000
| +306% | +$81.1M |
|
|
APO.PRA
302
DELISTED
Apollo Global Management Series A
APO.PRA
| $103M | 0.02% |
1,361,316
+169,142
| +14% | +$11.8M |
|
303
Skyworks Solutions
SWKS
$10.5B
| $102M | 0.02% |
+1,612,979
| New | +$113M |
|
304
Brookfield
BN
$111B
| $98M | 0.02% |
2,134,876
-44,233
| -2% | -$2.02M |
|
|
LINE
305
Lineage Inc
LINE
$9.8B
| $97.7M | 0.02% |
2,790,338
-362,611
| -12% | -$13.4M |
|
|
SII
306
Sprott
SII
$3.03B
| $97.1M | 0.02% |
991,339
+464,177
| +88% | +$41.2M |
|
307
Western Union
WU
$2.34B
| $96.9M | 0.02% |
10,407,960
+2,716,385
| +35% | +$24M |
|
308
Bio-Techne
TECH
$11.2B
| $95.2M | 0.02% |
1,618,882
-6,620
| -0.4% | -$402K |
|
309
KT
KT
$9.03B
| $94.2M | 0.02% |
4,966,590
+292,210
| +6% | +$5.45M |
|
310
Emerson Electric
EMR
$91.6B
| $93.4M | 0.02% |
703,547
+3,510
| +0.5% | +$466K |
|
311
State Street
STT
$52.2B
| $88M | 0.02% |
681,995
+55
| +0% | +$6.59K |
|
312
FirstCash
FCFS
$9.14B
| $85.6M | 0.02% |
536,961
+134,849
| +34% | +$21.3M |
|
313
Ollie's Bargain Outlet
OLLI
$4.7B
| $84.7M | 0.02% |
772,837
+318,865
| +70% | +$38.4M |
|
314
Steven Madden
SHOO
$3.46B
| $84.3M | 0.02% |
2,025,479
-694,875
| -26% | -$26.8M |
|
315
Klaviyo
KVYO
$5.47B
| $83.7M | 0.02% |
2,577,782
-15,361
| -0.6% | -$430K |
|
|
MASI
316
DELISTED
Masimo
MASI
| $83M | 0.02% |
637,894
-1,216,234
| -66% | -$174M |
|
317
Applied Industrial Technologies
AIT
$13.2B
| $82.8M | 0.02% |
322,594
-1,199
| -0.4% | -$307K |
|
318
Matsons
MATX
$6.39B
| $81.7M | 0.02% |
661,572
-2,253
| -0.3% | -$242K |
|
319
Southern Copper
SCCO
$158B
| $81M | 0.02% |
+582,254
| New | +$76.2M |
|
320
Lowe's Companies
LOW
$122B
| $80.6M | 0.01% |
334,199
+2,289
| +0.7% | +$550K |
|
321
Sanofi
SNY
$105B
| $80M | 0.01% |
+1,650,018
| New | +$81.8M |
|
322
Regeneron Pharmaceuticals
REGN
$83B
| $79.8M | 0.01% |
103,336
-2,413
| -2% | -$1.64M |
|
|
BWIN
323
Baldwin Insurance Group
BWIN
$2.99B
| $72.5M | 0.01% |
3,017,071
-1,496,179
| -33% | -$38.1M |
|
324
Southern Company
SO
$107B
| $72M | 0.01% |
825,154
+394
| +0% | +$36K |
|
325
Nutrien
NTR
$32.2B
| $71M | 0.01% |
1,151,049
+7,784
| +0.7% | +$458K |
|
Similar funds
Capital Research Global Investors's Q4 2025 Portfolio in Review
As of Q4 2025, Capital Research Global Investors held 465 positions worth $542B, up 1.6% from $533B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Capital Research Global Investors's Q4 2025 filing shows 31 new, 212 increased, 169 reduced and 31 closed positions. Its largest new stake was Medline Inc: 14,784,203 shares worth $621M. The largest sale was Meta Platforms (Facebook), an estimated $3.92B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q4 2025 buy was Medline Inc: 14,784,203 shares worth $621M.
- Capital Research Global Investors added most to Applied Materials in Q4 2025, an estimated $4.27B increase.
- Capital Research Global Investors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $3.92B.
- Capital Research Global Investors fully exited nVent Electric in Q4 2025, selling an estimated $379M.
- Capital Research Global Investors's ten largest holdings make up 39% of its $542B portfolio in Q4 2025.
- Capital Research Global Investors opened 31 new positions and closed 31 in Q4 2025.
- Capital Research Global Investors's portfolio value rose 1.6% quarter-over-quarter to $542B.
Based on Capital Research Global Investors's 13F filing for Q4 2025, filed 11 Feb 2026.